That will be the one-two punch by Leo. Followed closely on the PR announcing successful Brilacidin vs. Covid-19 clinical trial results, I anticipate a second PR announcing a term sheet relating to a licensing deal or partnership with a major Pharmaceutical company. GO KILLER "B."
Market Data 
Markets 
AI
